American Heart Association Report Finds Ultromics EchoGo May Detect HFpEF Earlier
The American Heart Association has released an AI Impact Report assessing Ultromics' EchoGo Heart Failure system. The findings, announced in a press release, show that the AI tool could detect heart failure with preserved ejection fraction (HFpEF) about 263 days earlier than standard diagnostic methods.
The analysis used retrospective real world data from Dandelion Health and was conducted through the American Heart Association's AI Assessment Lab. This evaluation estimated that earlier detection could lead to nearly 500 additional lives saved for every 10,000 patients under the modeled assumptions.
The report also projected potential financial benefits for health systems, estimating up to about 1.9 million dollars in additional revenue over five years. The assessment aimed to quantify both the clinical and economic value of cardiovascular AI tools like EchoGo Heart Failure in routine care.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 28 United Imaging Intelligence Releases Medical Video AI Framework Sep 28 Orca Dental AI Brings CephX Imaging Tools to Planet DDS Cloud 9 Sep 28 AINGENS Warns AI Tool Fragmentation Complicates Medical Affairs Work Sep 28 Blue Cross Analysis Links Hospital AI to $942 Million in Added Costs Sep 26 FDA Clears Nutshell Therapeutics' NRF2 Degrader NTS231Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Atman Health Wins ARPA-H Award to Build Heart Failure AI
ARPA-H Awards UpDoc Up to $9.2 Million for Clinical AI
Caristo Diagnostics Presents AI Heart CT Data at ESC Congress 2026
ZBeats Receives FDA Clearance for 14 Day ECG Analysis
Rhythm AI Study Reports 90% Freedom From Atrial Fibrillation
Daily AI Brief: the AI news that matters, in your inbox.